Ivacaftor d18 | CAS 1413431-05-6 - Request Quote
Ivacaftor d18
| SZ CAT No: | SZ-I015D03 |
| CAS No | 1413431-05-6 |
| Mol.F. | C24H10D18N2O3 |
| Mol.Wt. | 410.6 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Ivacaftor d18 is chemically N-(5-Hydroxy-2,4-bis(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide. Ivacaftor d18 is supplied with detailed characterization data compliant with regulatory guideline. Ivacaftor d18 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ivacaftor.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1413431-05-6
Purchase 1413431-05-6
Order 1413431-05-6
Enquire 1413431-05-6
price of 1413431-05-6
1413431-05-6 Supplier
1413431-05-6 Manufacturer
1413431-05-6 Exporter
buy high quality Ivacaftor d18
Purchase Ivacaftor d18
Ivacaftor d18 suppliers
Ivacaftor d18 manufacturers
Ivacaftor d18 price
Order Ivacaftor d18
Enquire Ivacaftor d18
Ivacaftor d18 cost
Ivacaftor d18 Supplier
Ivacaftor d18 Distributor
Ivacaftor d18 for Method Validation
Ivacaftor Reference Standard
Ivacaftor d18 for ANDA Filing
Ivacaftor d18 for Forced Degradation Studies
Ivacaftor d18 Identification Standards
Ivacaftor d18 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


